Existing shareholders of Pfizer as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
Shareholders can apply for Pfizer rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
No! Participation in Pfizer rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
No, Pfizer hasn’t had any right issues as of {{current_date}} in last 2023-2025
No, Pfizer hasn’t had any right issues as of {{current_date}} in last 2023-2025